AMY CHANDLER: Open Payments
NPI 1205266723 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 11 payments from 8 companies in 2025. Trend: 2023 $535 · 2024 $450 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| United Therapeutics Corporation | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $23 |
| 3B Medical, Inc. | 1 | $7 |
Products named: DUPIXENT, Tyvaso, GLASSIA, OPSYNVI, ACTHAR, TEZSPIRE, Fluid Systems - Premix Drugs, FASENRA.
Industry payments across MD — which companies pay providers there.
